{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:07:48Z","timestamp":1790942868449,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006815","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000}}],"reference-count":77,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006815.pub2","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T14:50:40Z","timestamp":1291042240000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Hydroxyzine for generalised anxiety disorder"],"prefix":"10.1002","volume":"2010","author":[{"given":"Giuseppe","family":"Guaiana","sequence":"first","affiliation":[{"name":"University of Western Ontario; Department of Psychiatry; Regional Mental Health Care-Saint Thomas 467 Sunset Drive St Thomas Ontario Canada N6P 3V9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Barbui","sequence":"additional","affiliation":[{"name":"University of Verona; Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology; Policlinico \"GB Rossi\" Piazzale L.A. Scuro, 10 Verona Italy 37134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"University of Verona; Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology; Policlinico \"GB Rossi\" Piazzale L.A. Scuro, 10 Verona Italy 37134"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"10.1002\/14651858.CD006815.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hup.470100303","article-title":"A multicentre double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety","volume":"10","author":"Darcis","year":"1995","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0033-3182(73)71372-4","article-title":"The use of hydroxyzine (Vistaril) in the treatment of anxiety neurosis","volume":"14","author":"Goldberg","year":"1973","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130050731","article-title":"A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder","volume":"139","author":"Lader","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4088\/JCP.v63n1112","article-title":"Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double blind study","volume":"63","author":"Llorca","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0010-440X(70)90006-4","article-title":"Hydroxyzine and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study","volume":"5","author":"Rickels","year":"1970","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0006|cit6","first-page":"217","article-title":"Treatment of anxiety with oral hydroxyzine: an overview","volume":"22","author":"Barranco","year":"1977","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0007|cit7","first-page":"421","article-title":"Evaluation of hydroxyzine pamoate concentrate as an ataractic: double-blind crossover study in a neurotic male prison group","volume":"10","author":"Breslow","year":"1968","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/070674376000500212","article-title":"Hydroxyzine hydrochloride and chlorpromazine: a clinical trial with a group of \"tense\" psychiatric patients","volume":"5","author":"Burrell","year":"1960","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0009|cit9","first-page":"1157","article-title":"Clinical study of hydroxyzine in somatic and psychic manifestations of anxiety","volume":"26","author":"Choussat","year":"1984","journal-title":"La Vie Medicale"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/hup.470050408","article-title":"Effect of hydroxyzine on attention and memory","volume":"5","author":"Brabander","year":"1990","journal-title":"Human Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD006815.pub2-BIB0011|cit11","first-page":"443","article-title":"Management of emotional disturbances: use of hydroxyzine (Atarax) in general practice","volume":"88","author":"Dolan","year":"1958","journal-title":"California Medicine"},{"issue":"11","key":"10.1002\/14651858.CD006815.pub2-BIB0012|cit12","first-page":"503","article-title":"Clinical evaluation of Atarax: a non-barbiturate calming agent","volume":"83","author":"Ende","year":"1956","journal-title":"Virginia Medical Monthly"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0013|cit13","first-page":"379","article-title":"Preliminary study on the use of hydroxyzine in psychosomatic affections","volume":"1","author":"Farah","year":"1956","journal-title":"International Records of Medicine and GP Clinics"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0014|cit14","first-page":"785","article-title":"Advantages of hydroxyzine in generalized anxiety disorder : A double-blind controlled versus placebo study","volume":"20","author":"Ferreri","year":"1994","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0015|cit15","first-page":"549","article-title":"Management of tension and anxiety states with hydroxyzine hydrochloride","volume":"45","author":"Garber","year":"1958","journal-title":"Journal of the Florida Medical Association"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0016|cit16","first-page":"10","article-title":"Example of hydroxyzine with detailed analysis of its anxiolytic effects on the FARD scale","volume":"8","author":"Hantouche","year":"1995","journal-title":"Nervure"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1002\/(SICI)1099-1077(199908)14:1+<S87::AID-HUP122>3.0.CO;2-F","article-title":"Interactions between psychotherapy and drug therapy in Generalized Anxiety Disorder","volume":"14","author":"Hantouche","year":"1999","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0018|cit18","first-page":"381","article-title":"Anxiolysis as a modifying factor of certain neuropsychiatric parameters in patients with coronary heart disease: a double blind placebo-controlled trial of hydroxyzine hydrochloride","volume":"14","author":"Karakostas","year":"1990","journal-title":"Acta Therapeutica"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1192\/bjp.114.512.863","article-title":"The assessment of changes in anxiety in a drug trial: a comparison of methods","volume":"114","author":"Kellner","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/(SICI)1099-1077(199908)14:1+<S94::AID-HUP123>3.0.CO;2-K","article-title":"Anxiolytic effect of hydroxyzine: a double blind trial versus placebo and buspirone","volume":"14","author":"Lader","year":"1999","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0021|cit21","first-page":"290","article-title":"Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo","volume":"23","author":"Lemoine","year":"1997","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0022|cit22","first-page":"127","article-title":"Pharmcological study on hydroxyzine, U.C.B. 492; a disubstituted piperazine derivative","volume":"109","author":"Levis","year":"1957","journal-title":"Archives Internationals de Pharmacodynamie e de Therapie"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0023|cit23","first-page":"60","article-title":"High dosages of hydroxyzine in out-patient treatment of severe neuroses and psychoses","volume":"64","author":"Lipton","year":"1961","journal-title":"The Pennsylvania Medical Journal"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1967.01730220083012","article-title":"Stress: psychophysiological and cognitive indices in an acute double-blind study with hydroxyzine in psychiatric patients","volume":"16","author":"Pishkin","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0025|cit25","first-page":"498","article-title":"Hydroxyzine for controlling postpartum anxiety: a double-blind study","volume":"52","author":"Reisner","year":"1967","journal-title":"Nebraska State Medical Journal"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archpsyc.1966.01730120071009","article-title":"Compliance and improvement in drug-treated and placebo treated neurotic outpatients","volume":"14","author":"Rickels","year":"1966","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0027|cit27","first-page":"249","article-title":"Prognostic indicators of 4-week clinical improvement with chlordiazepoxide and hydroxyzine in anxious neurotic outpatients","volume":"6","author":"Rickels","year":"1971","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/00007611-195710000-00015","article-title":"Hydroxyzine hydrochloride (Atarax): a new tranquillizer","volume":"50","author":"Robinson","year":"1957","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0029|cit29","first-page":"147","article-title":"Effects on cognitive functions by two anxiolytic treatments on patients with generalized anxiety disorder","volume":"21","author":"Samuelian","year":"1995","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0030|cit30","first-page":"1584","article-title":"Observations on the use of hydroxyzine in anxiety-tension states and senile agitation","volume":"8","author":"Settel","year":"1957","journal-title":"American Practitioner"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0031|cit31","first-page":"312","article-title":"Hydroxyzine: a new therapeutic agent for senile anxiety states; a preliminary report","volume":"11","author":"Shalowitz","year":"1956","journal-title":"Geriatrics"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0032|cit32","first-page":"357","article-title":"Evaluation of an ataraxic: hydroxyzine in long term therapy","volume":"174","author":"Shalowitz","journal-title":"1961"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0033|cit33","first-page":"663","article-title":"Hydroxyzine, amitriptyline and their combination in the treatment of psychoneurotic patients","volume":"11","author":"Silver","year":"1969","journal-title":"Current Therapeutic Research 1969"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1532-5415.1959.tb00580.x","article-title":"Emotional and psychic problems of institutionalized geriatric patients: evaluation of hydroxyzine","volume":"7","author":"Smigel JO. Lowe","year":"1959","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0035|cit35","first-page":"37","article-title":"Hydroxyzine, sedation of anxiety and functional symptomatology: a collaborative study","volume":"28","author":"Weber","year":"1987","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0036|cit36","first-page":"421","article-title":"A comparative trial between two tranquillizers","volume":"10","author":"Clyne","year":"1968","journal-title":"The Practitioner"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0037|cit37","first-page":"168","article-title":"A clinical evaluation of hydroxyzine and placebo in anxious psychiatric outpatients","volume":"1","author":"Mock","year":"1965","journal-title":"International Journal of Neuropsychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0038|cit38","first-page":"53","article-title":"[A multicentre double-blind study investigating the anxiolitic efficacy of diazepam, hydroxyzine and tofisopam in patients with generalized anxiety]","volume":"3","author":"Rzewuska","year":"2003","journal-title":"Farmakoterapia w Psychiatrii i Neurologii [Pharmacotherapy in Psychiatry and Neurology]"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0039|cit39","first-page":"316","article-title":"Doxepin in the treatment of neuroses: a comparative clinical study of doxepin, chlordiazepoxide, hydroxyzine, meprobamate and phenobarbital","volume":"22","author":"Saint-Laurent","year":"1977","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0040|cit40","first-page":"195","article-title":"The place of doxepin among the anxiolytic-sedative drugs","volume":"14","author":"Sterlin","year":"1972","journal-title":"Current Therapeutic Research"},{"issue":"7066","key":"10.1002\/14651858.CD006815.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006815.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10673220303944","article-title":"Anxiety symptoms and generalized anxiety disorder in the elderly: a review","volume":"11","author":"Alwahabbi","year":"2003","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0043|cit43","volume-title":"Diagnostic and statistical manual of mental disorders - DSM-III","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0044|cit44","volume-title":"Diagnostic and statistical manual of mental disorders - DSM-III-R","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0045|cit45","volume-title":"Diagnostic and statistical manual of mental disorders - DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0046|cit46","first-page":"1","article-title":"Discontinuation symptoms in depression and anxiety disorders","volume":"19","author":"Baldwin","year":"2005","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0047|cit47","first-page":"217","article-title":"Treatment of anxiety with oral hydroxyzine: an overview","volume":"22","author":"Barranco","year":"1977","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archpsyc.1988.01800360048007","article-title":"The prevalence of psychiatric disorders in a primary care practice","volume":"45","author":"Barrett","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1176\/ajp.150.8.1216","article-title":"Psychiatric comorbidity in patients with generalized anxiety disorders","volume":"150","author":"Brawman-Mintzer","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/0470846437.ch10","article-title":"Generalised anxiety disorder","volume-title":"Anxiety Disorders","author":"Caycedo","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD006815.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006115","article-title":"Azapirones for generalized anxiety disorder","author":"Chessick","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/YCO.0b013e32831a473d","article-title":"Current use of benzodiazepines in anxiety disorders","volume":"22","author":"Cloos","year":"2009","journal-title":"Current Opinion in Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006815.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/JCP.s.7002.05","article-title":"First-line pharmacotherapy approaches for Generalized Anxiety Disorder","volume":"70","author":"Davidson","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.1998.tb05974.x","article-title":"Recent clinical trials of hydroxyzine in generalized anxiety disorder","volume":"393","author":"Ferreri","year":"1998","journal-title":"Acta Psychiatrica Scandinavica, Supplementum"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Pscyhopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0057|cit57","doi-asserted-by":"crossref","DOI":"10.1002\/0470846437","volume-title":"Anxiety Disorders","author":"Griez","year":"2001"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0058|cit58","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology","volume-title":"US Department of Health, Education, and Welfare publication","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"31","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0269881107076996","article-title":"An effect-size analysis of pharmacologic treatments for generalized anxiety disorder","volume":"21","author":"Hidalgo","year":"2007","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0061|cit61","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD006815.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/msj.20041","article-title":"Anxiety disorders: a comprehensive review of pharmacotherapies","volume":"75","author":"Hoffman","year":"2008","journal-title":"Mount Sinai Journal of Medicine"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.psc.2009.05.002","article-title":"Psychotherapy for generalized anxiety disorder: don't worry, it works","volume":"32","author":"Hoyer","year":"2009","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/sim.3487","article-title":"A re-evaluation of the \"quantile approximation method\" for random effects meta-analysis","volume":"28","author":"Jackson","year":"2009","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006815.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003592","article-title":"Antidepressants for generalized anxiety disorder","author":"Kapczinski","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archpsyc.55.9.801","article-title":"Lifetime depression comorbidity in the National Comorbidity Survey","volume":"55","author":"Kessler","year":"1998","journal-title":"Archvies of General Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-5198(19)43508-7","article-title":"Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay","volume":"43","author":"Kubo","year":"1987","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0069|cit69","first-page":"7","article-title":"Anxiolysis as a modifying factor of certain neuropsychiatric parameters in patients with coronary heart diseases","volume":"April","author":"Papadopoulous","year":"1990","journal-title":"Neurologie Psychiatrie"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S1516-44462005000100007","article-title":"The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis","volume":"27","author":"Schmitt","year":"2005","journal-title":"Revista Brasileria de Psiquiatria"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0072|cit72","first-page":"367","article-title":"Evaluation of an ataraxic (hydroxyzine) in long-term therapy","volume":"174","author":"Shalowitz","year":"1961","journal-title":"International Records in Medicine"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0073|cit73","first-page":"449","article-title":"Antidepressant discontinuation syndrome","volume":"74","author":"Warner","year":"2006","journal-title":"American Family Physician"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006815.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.s.7002.01","article-title":"Overview of generalized anxiety disorder: epidemiology, presentation, and course","volume":"70","author":"Weisberg","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0075|cit75","volume-title":"The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)","author":"World Health Organization","year":"1978"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0076|cit76","volume-title":"The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD006815.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archpsyc.1994.03950050015002","article-title":"DSM-III-R generalized anxiety disorder in the National Comorbidity Survey","volume":"51","author":"Wittchen","year":"1994","journal-title":"Archives of General Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006815.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:47:51Z","timestamp":1777956471000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006815.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":77,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006815.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}